A9697 HCPCS Level II code: Injection, carboxydextran-coated superparamagnetic iron oxide, per study dose
A9697 is the HCPCS code for “Injection, carboxydextran-coated superparamagnetic iron oxide, per study dose” in CMS’s October 2026 release, in effect from Oct 1, 2026.
Official description
A9697Injection, carboxydextran-coated superparamagnetic iron oxide, per study dose
Short description: Inj, magtrace per study dose
HCPCS · United States
Medicare details
The indicators CMS publishes with A9697 in its October 2026 file. They describe Medicare’s handling, not another payer’s.
- Medicare coverage
- Carrier judgment
- Medicare pricing
- Drugs
- ASC
- Approved for ambulatory surgical centers
- Type of service
- Diagnostic radiology
- BETOS category
- Standard imaging - nuclear medicine
- Added
- Oct 1, 2023
Where A9697 sits
- 1A codesAmbulance, supplies and miscellaneous
- 2Active code A9697Injection, carboxydextran-coated superparamagnetic iron oxide, per study dose
Source and release
- Data release
- HCPCS Level II · October 2026
- Effective date
- Oct 1, 2026
- Publisher
- CMS
This page is built from the HCPCS Level II catalog that Vero Codes reads when it suggests codes: Centers for Medicare & Medicaid Services’s October 2026 release, imported from the publisher’s file and checked against it. The description, notes and structured data come from the same record.
Frequently asked questions
What does HCPCS code A9697 mean?
A9697 is the HCPCS code for “Injection, carboxydextran-coated superparamagnetic iron oxide, per study dose” in CMS’s HCPCS Level II October 2026 release.
Does Medicare cover A9697?
CMS lists A9697’s Medicare coverage as “Carrier judgment” and its pricing as “Drugs”. Coverage and payment still depend on the patient, the setting, the documentation and the payer.
Which HCPCS Level II release does this page use?
It uses CMS’s October 2026 release, in effect from Oct 1, 2026 to Dec 31, 2026. It is a reference: confirm the code against the current list and the payer’s rules before you submit it.
Codes beside A9697
All A codesA9610Xenon xe-129 hyperpolarized gas, diagnostic, per study doseA9611Flurpiridaz f 18, diagnostic, 1 millicurieA9612Injection, fluorescein, 1 mgA9613Piflufolastat f 18 (pylarify truvu), diagnostic, 1 millicurieA9615Injection, pegulicianine, 1 mgA9616Gallium ga-68 gozetotide (gozellix), diagnostic, 1 millicurieA9698Non-radioactive contrast imaging material, not otherwise classified, per studyA9699Radiopharmaceutical, therapeutic, not otherwise classifiedA9700Supply of injectable contrast material for use in echocardiography, per studyA9800Gallium ga-68 gozetotide, diagnostic, (locametz), 1 millicurieA9900Miscellaneous dme supply, accessory, and/or service component of another hcpcs codeA9901Dme delivery, set up, and/or dispensing service component of another hcpcs code